Indication

Neuropathic Pain

51 clinical trials

54 products

4 drugs

Product
iN1011-N17
Product
Praga
Product
Pregabalin
Product
Placebo
Product
Adezunap
Product
Sativex
Product
NFX88
Product
PLACEBO
Product
Vitamin C
Product
XT-150
Product
Sativex®
Product
AJH-2947
Clinical trial
Impact of Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy
Status: Recruiting, Estimated PCD: 2027-03-31
Product
Metamizol
Product
Ketoprofen
Product
Morphine
Product
Duloxetine
Product
Lidocaine
Product
Placebos
Product
dronabinol
Clinical trial
Capsaicin in Digital Osteoarthritis Versus Control : a Randomized Study
Status: Not yet recruiting, Estimated PCD: 2028-01-01
Product
Capsaicin
Clinical trial
Intrathecal Targeted Drug Delivery for Cancer Associated Pain
Status: Recruiting, Estimated PCD: 2024-06-06
Product
Ketamine
Clinical trial
Exploring the Genetics of Neuropathic Pain
Status: Recruiting, Estimated PCD: 2027-01-01
Clinical trial
Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
Status: Terminated, Estimated PCD: 2022-10-10
Product
Oxytocin
Clinical trial
Efficacy of Gabapentin in Treating Pain in Children With Severe Neurological Impairment
Status: Recruiting, Estimated PCD: 2026-03-31
Product
Gabapentin
Product
NDMC
Product
EC5026
Clinical trial
Use of PET/MRI in the Diagnosis of Pediatric Chronic Pain
Status: , Estimated PCD: 2024-12-31
Clinical trial
Phase II Study of Intrathecal Ziconotide for the Treatment of Neuropathic Pain in Patients With Cancer
Status: Active (not recruiting), Estimated PCD: 2024-12-01
Product
ziconotide
Product
Lidocain
Product
Methadone
Clinical trial
Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain
Status: Recruiting, Estimated PCD: 2024-12-31
Product
Lacosamide
Product
Calcitonin